Diagnosis and treatment of metastatic and castration resistant prostate cancer became more and more and complex due to the increasing knowledge and understanding of the underlying molecular events and the subsequently deducted innovative medical treatment
Modern imaging studies in CRPCA have become more and more complex and selective and currently include positron emission tomography, whole body magnetic resonance imaging, immunoscintigraphy besides the traditional studies such as bone scans and computed tomography.
About the Editors
Kurt Miller MD, PhD
Professor Miller has been Chairman and Professor of Urology for the Department of Urology at the Benjamin Franklin Medical Center, Berlin, Germany, since 1993. In 2007 he became Chairman of the ...
Read more »
Axel Merseburger MD, PhD
Prof Axel S. Merseburger is currently Vice Chairman of the Department of Urologic Oncology, as well as Director of the Urologic Oncology Programme at Hannover Medical School, Germany. ...
Read more »
17 September - 19 September
11th Meeting of the EAU Robotic Urology Section (ERUS)
Amsterdam, The Netherlands
Contact: Congress Consultants B.V.
Tel.: +31 26 389 1751
Fax: +31 26 389 1752
18 September - 21 September
South African Urological Association (SAUA) Congress
Camps Bay, Cape Town, South Africa
Contact: South African Urological Association
Tel.: +33 345 7872
Fax: +33 342 7142
18 September - 20 September
26th Annual Meeting of the German Society of Andrology
Contact: German Society of Andrology (DGA)
Tel.: +49 3641 31 16-362
Fax: +49 3641 31 16-243